Detalles de la búsqueda
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587254
2.
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.
Am Heart J
; 231: 121-127, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33065120
3.
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
Circulation
; 134(24): 1918-1930, 2016 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27881559
4.
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.
J Am Coll Cardiol
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38588930
5.
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial.
J Cardiovasc Pharmacol Ther
; 27: 10742484221121507, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36282079
6.
Early and late recurrent cardiovascular events among high-risk patients with an acute coronary syndrome: Meta-analysis of phase III studies and implications on trial design.
Clin Cardiol
; 45(3): 299-307, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35019162
7.
Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A-I [Human]) to Enhance Cholesterol Efflux Capacity.
J Clin Pharmacol
; 59(3): 427-436, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30452776
8.
Developing New Treatments for Heart Failure: Focus on the Heart.
Circ Heart Fail
; 9(5)2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27166246
9.
Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction.
Eur J Heart Fail
; 15(6): 679-89, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23471413
Resultados
1 -
9
de 9
1
Próxima >
>>